Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Shares Outstanding 2006-2018 | GILD

Gilead Sciences shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Gilead Sciences shares outstanding for the quarter ending December 31, 2018 were 1.308B, a 0.83% decline year-over-year.
  • Gilead Sciences 2018 shares outstanding were 1.308B, a 0.83% decline from 2017.
  • Gilead Sciences 2017 shares outstanding were 1.319B, a 2.87% decline from 2016.
  • Gilead Sciences 2016 shares outstanding were 1.358B, a 10.72% decline from 2015.
Gilead Sciences Annual Shares Outstanding
(Millions of Shares)
2018 1,308
2017 1,319
2016 1,358
2015 1,521
2014 1,647
2013 1,695
2012 1,583
2011 1,580
2010 1,747
2009 1,868
2008 1,918
2007 1,929
2006 1,836
2005 1,897
Gilead Sciences Quarterly Shares Outstanding
(Millions of Shares)
Q4 2018 1,308
Q3 2018 1,307
Q2 2018 1,308
Q1 2018 1,320
Q4 2017 1,319
Q3 2017 1,319
Q2 2017 1,317
Q1 2017 1,320
Q4 2016 1,358
Q3 2016 1,339
Q2 2016 1,355
Q1 2016 1,412
Q4 2015 1,521
Q3 2015 1,503
Q2 2015 1,540
Q1 2015 1,569
Q4 2014 1,647
Q3 2014 1,637
Q2 2014 1,664
Q1 2014 1,680
Q4 2013 1,695
Q3 2013 1,692
Q2 2013 1,695
Q1 2013 1,665
Q4 2012 1,583
Q3 2012 1,585
Q2 2012 1,561
Q1 2012 1,555
Q4 2011 1,580
Q3 2011 1,563
Q2 2011 1,602
Q1 2011 1,624
Q4 2010 1,747
Q3 2010 1,694
Q2 2010 1,798
Q1 2010 1,857
Q4 2009 1,868
Q3 2009 1,865
Q2 2009 1,869
Q1 2009 1,885
Q4 2008 1,918
Q3 2008 1,921
Q2 2008 1,931
Q1 2008 1,933
Q4 2007 1,929
Q3 2007 1,918
Q2 2007 1,936
Q1 2007 1,925
Q4 2006 1,836
Q3 2006 1,830
Q2 2006 1,905
Q1 2006 1,927
Q4 2005 1,897
Q3 2005 1,904
Q2 2005 1,890
Q1 2005 1,870
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $82.806B $22.127B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.409B 13.32
Celgene (CELG) United States $62.952B 11.64
Illumina (ILMN) United States $46.924B 55.81
Vertex Pharmaceuticals (VRTX) United States $46.673B 62.52
Biogen (BIIB) United States $44.629B 8.65
Regeneron Pharmaceuticals (REGN) United States $43.993B 20.44
Alexion Pharmaceuticals (ALXN) United States $29.992B 18.59
Incyte (INCY) United States $18.640B 174.16
BioMarin Pharmaceutical (BMRN) United States $16.193B 0.00
Seattle Genetics (SGEN) United States $12.092B 0.00
Exact Sciences (EXAS) United States $11.573B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.642B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.441B 53.86
QIAGEN (QGEN) Netherlands $9.095B 30.10
Sarepta Therapeutics (SRPT) United States $9.030B 0.00
Bluebird Bio (BLUE) United States $8.582B 0.00
BeiGene (BGNE) Cayman Islands $8.117B 0.00
Bio-Techne Corp (TECH) United States $7.570B 51.00
Guardant Health (GH) United States $7.310B 0.00
Exelixis (EXEL) United States $7.287B 16.98
Moderna (MRNA) United States $6.363B 0.00
Amarin (AMRN) Ireland $6.058B 0.00
Alkermes (ALKS) Ireland $5.452B 0.00
Galapagos (GLPG) Belgium $5.255B 0.00
Array BioPharma (ARRY) United States $5.235B 0.00
Ascendis Pharma (ASND) Denmark $5.179B 0.00
Horizon Pharma Public (HZNP) Ireland $4.734B 15.25
Spark Therapeutics (ONCE) United States $4.300B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.247B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.916B 0.00
Blueprint Medicines (BPMC) United States $3.725B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.540B 0.00
Immunomedics (IMMU) United States $3.483B 0.00
China Biologic Products (CBPO) China $3.480B 21.57
Intercept Pharmaceuticals (ICPT) United States $3.419B 0.00
Allogene Therapeutics (ALLO) United States $3.314B 0.00
Amicus Therapeutics (FOLD) United States $3.092B 0.00
Global Blood Therapeutics (GBT) United States $2.957B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $2.952B 0.00
Reata Pharmaceuticals (RETA) United States $2.788B 0.00
Genomic Health (GHDX) United States $2.754B 70.41
Repligen (RGEN) United States $2.713B 83.46
Mirati Therapeutics (MRTX) United States $2.657B 0.00
Ligand Pharmaceuticals (LGND) United States $2.641B 19.72
Akcea Therapeutics (AKCA) United States $2.633B 0.00
UniQure (QURE) Netherlands $2.574B 0.00
Emergent Biosolutions (EBS) United States $2.509B 20.94
Myriad Genetics (MYGN) United States $2.456B 25.01
Acceleron Pharma (XLRN) United States $2.433B 0.00
Halozyme Therapeutics (HALO) United States $2.393B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.359B 0.00
REGENXBIO (RGNX) United States $2.274B 23.75
Insmed (INSM) United States $2.262B 0.00
Arena Pharmaceuticals (ARNA) United States $2.258B 0.00
MyoKardia (MYOK) United States $2.251B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.196B 0.00
Medicines (MDCO) United States $2.069B 0.00
AnaptysBio (ANAB) United States $2.035B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.979B 0.00
Denali Therapeutics (DNLI) United States $1.936B 0.00
NeoGenomics (NEO) United States $1.876B 152.62
Atara Biotherapeutics (ATRA) United States $1.846B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.739B 0.00
Audentes Therapeutics (BOLD) United States $1.688B 0.00
Myovant Sciences (MYOV) United Kingdom $1.676B 0.00
Allakos (ALLK) United States $1.639B 0.00
Puma Biotechnology (PBYI) United States $1.555B 0.00
WAVE Life Sciences (WVE) Singapore $1.504B 0.00
GOSSAMER BIO (GOSS) United States $1.471B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.429B 0.00
Innoviva (INVA) United States $1.411B 3.89
Momenta Pharmaceuticals (MNTA) United States $1.389B 0.00
Clovis Oncology (CLVS) United States $1.381B 0.00
Rubius Therapeutics (RUBY) United States $1.379B 0.00
Aimmune Therapeutics (AIMT) United States $1.372B 0.00
Cambrex (CBM) United States $1.321B 14.23
Lion Biotechnologies (IOVA) United States $1.272B 0.00
ALECTOR INC (ALEC) United States $1.266B 0.00
Apellis Pharmaceuticals (APLS) United States $1.245B 0.00
Editas Medicine (EDIT) United States $1.215B 0.00
Fate Therapeutics (FATE) United States $1.154B 0.00
Codexis (CDXS) United States $1.131B 0.00
Epizyme (EPZM) United States $1.108B 0.00
Coherus BioSciences (CHRS) United States $1.074B 0.00
InflaRx (IFRX) Germany $1.062B 0.00
RA PHARMCTL INC (RARX) United States $1.055B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.055B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.011B 0.00
Sangamo Therapeutics (SGMO) United States $1.002B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.986B 0.00
Retrophin (RTRX) United States $0.983B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.980B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.971B 39.23
Dicerna Pharmaceuticals (DRNA) United States $0.958B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.943B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.934B 0.00
Principia Biopharma (PRNB) United States $0.886B 0.00
Athenex (ATNX) United States $0.848B 0.00
Vericel (VCEL) United States $0.847B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.844B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.835B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.825B 0.00
Eidos Therapeutics (EIDX) United States $0.806B 0.00
Intellia Therapeutics (NTLA) United States $0.797B 0.00
Cellectis (CLLS) France $0.777B 0.00
Cara Therapeutics (CARA) United States $0.777B 0.00
ANI Pharmaceuticals (ANIP) United States $0.763B 13.97
Intra-Cellular Therapies (ITCI) United States $0.717B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.714B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.711B 0.00
Revance Therapeutics (RVNC) United States $0.703B 0.00
Acorda Therapeutics (ACOR) United States $0.669B 8.67
Viking Therapeutics (VKTX) United States $0.668B 0.00
Heska (HSKA) United States $0.665B 59.65
Osiris Therapeutics (OSIR) United States $0.661B 0.00
Twist Bioscience (TWST) United States $0.656B 0.00
Synthorx (THOR) United States $0.648B 0.00
Sorrento Therapeutics (SRNE) United States $0.640B 0.00
Magenta Therapeutics (MGTA) United States $0.612B 0.00
Kura Oncology (KURA) United States $0.608B 0.00
ObsEva SA (OBSV) Switzerland $0.583B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.582B 0.00
Stemline Therapeutics (STML) United States $0.578B 0.00
G1 THERAPEUTICS (GTHX) United States $0.561B 0.00
Zealand Pharma (ZEAL) Denmark $0.555B 6.17
NuCana Sponsored ADR (NCNA) United Kingdom $0.549B 0.00
Arvinas (ARVN) United States $0.546B 0.00
MeiraGTx Holdings (MGTX) United States $0.541B 0.00
Prothena (PRTA) Ireland $0.530B 0.00
Arcus Biosciences (RCUS) United States $0.528B 0.00
UROGEN PHARMA (URGN) Israel $0.506B 0.00
Scholar Rock Holding (SRRK) United States $0.506B 0.00
CytomX Therapeutics (CTMX) United States $0.503B 0.00
Zymeworks (ZYME) Canada $0.486B 0.00
DBV Technologies (DBVT) France $0.486B 0.00
PDL BioPharma (PDLI) United States $0.486B 10.83
Cytokineticsorporated (CYTK) United States $0.485B 0.00
Dynavax Technologies (DVAX) United States $0.484B 0.00
Five Prime Therapeutics (FPRX) United States $0.483B 0.00
Replimune (REPL) United States $0.471B 0.00
Mesoblast (MESO) Australia $0.458B 0.00
AVROBIO (AVRO) United States $0.456B 0.00
Senesco Technologies (ELOX) United States $0.449B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.441B 0.00
Axsome Therapeutics (AXSM) United States $0.441B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.434B 0.00
Anika Therapeutics (ANIK) United States $0.427B 16.17
XBiotech (XBIT) United States $0.419B 0.00
MannKind (MNKD) United States $0.412B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.401B 0.00
Agenus (AGEN) United States $0.400B 0.00
Abeona Therapeutics (ABEO) United States $0.398B 0.00
BeyondSpring (BYSI) United States $0.393B 0.00
Adverum Biotechnologies (ADVM) United States $0.380B 0.00
BioDelivery Sciences (BDSI) United States $0.376B 0.00
Kadmon Holdings (KDMN) United States $0.376B 0.00
Solid Biosciences (SLDB) United States $0.374B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
MediciNova (MNOV) United States $0.366B 0.00
Inovio Pharmaceuticals (INO) United States $0.363B 0.00
Albireo Pharma (ALBO) United States $0.362B 0.00
STEALTH BIOTHER (MITO) United States $0.356B 0.00
UNITY Biotechnology (UBX) $0.351B 0.00
Krystal Biotech (KRYS) United States $0.346B 0.00
Kezar Life Sciences (KZR) United States $0.345B 0.00
Kindred Biosciences (KIN) United States $0.344B 0.00
Geron (GERN) United States $0.341B 0.00
Urovant Sciences (UROV) United States $0.334B 0.00
Gritstone Oncology (GRTS) United States $0.332B 0.00
OSMOTICA PHARM (OSMT) United States $0.328B 0.00
Syros Pharmaceuticals (SYRS) United States $0.314B 0.00
Protagonist Therapeutics (PTGX) United States $0.311B 0.00
Aduro Biotech (ADRO) United States $0.308B 0.00
Cellular Biomedicine (CBMG) United States $0.307B 0.00
Constellation Pharmaceuticals (CNST) United States $0.297B 0.00
AC Immune SA (ACIU) Switzerland $0.296B 0.00
Merus (MRUS) Netherlands $0.293B 0.00
Strongbridge Biopharma (SBBP) United States $0.291B 0.00
Gamida Cell (GMDA) Israel $0.289B 0.00
Novavax (NVAX) United States $0.276B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.276B 0.00
Seres Therapeutics (MCRB) United States $0.275B 0.00
Evelo Biosciences (EVLO) United States $0.274B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.274B 0.00
Enochian BioSciences (ENOB) United States $0.271B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.263B 0.00
Kala Pharmaceuticals (KALA) United States $0.261B 0.00
Verastem (VSTM) United States $0.257B 0.00
TOCAGEN INC (TOCA) United States $0.253B 0.00
Sutro Biopharma (STRO) United States $0.253B 0.00
Cerecor (CERC) United States $0.253B 0.00
Kodiak Sciences (KOD) United States $0.252B 0.00
Avid Bioservices (CDMO) United States $0.246B 0.00
BioTime (BTX) United States $0.242B 0.00
Athersys (ATHX) United States $0.238B 0.00
Kamada (KMDA) Israel $0.237B 10.69
Aeglea BioTherapeutics (AGLE) United States $0.236B 0.00
Intec Pharma (NTEC) Israel $0.228B 0.00
Spero Therapeutics (SPRO) United States $0.227B 0.00
Axovant Sciences (AXGT) United Kingdom $0.224B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.223B 0.00
Proteostasis Therapeutics (PTI) United States $0.219B 0.00
Mersana Therapeutics (MRSN) United States $0.219B 0.00
ChromaDex (CDXC) United States $0.218B 0.00
Celyad SA (CYAD) Belgium $0.216B 0.00
LogicBio Therapeutics (LOGC) United States $0.215B 0.00
Celcuity (CELC) United States $0.211B 0.00
Arbutus Biopharma (ABUS) Canada $0.208B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.204B 0.00
Palatin Technologies (PTN) United States $0.203B 100.00
Synlogic (SYBX) United States $0.200B 0.00
CorMedix Inc (CRMD) United States $0.199B 0.00
Pfenex (PFNX) United States $0.197B 0.00
VBI Vaccines (VBIV) United States $0.192B 0.00
Compugen (CGEN) Israel $0.189B 0.00
OvaScience (MLND) United States $0.186B 0.00
Menlo Therapeutics (MNLO) United States $0.183B 0.00
ResTORbio (TORC) United States $0.181B 0.00
Cue Biopharma (CUE) United States $0.179B 0.00
Liquidia Technologies (LQDA) United States $0.174B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.168B 0.00
ADMA Biologics Inc (ADMA) United States $0.162B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.157B 0.00
Trevena (TRVN) United States $0.155B 0.00
PHASEBIO PHARMA (PHAS) United States $0.153B 0.00
Anavex Life Sciences (AVXL) United States $0.147B 0.00
Allena Pharmaceuticals (ALNA) United States $0.147B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.146B 0.00
BioXcel Therapeutics (BTAI) United States $0.146B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.140B 0.00
Cohbar (CWBR) United States $0.137B 0.00
Eton Pharmaceuticals (ETON) United States $0.136B 0.00
Aptinyx (APTX) United States $0.135B 0.00
Unum Therapeutics (UMRX) United States $0.135B 0.00
Organovo Holdings (ONVO) United States $0.133B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.132B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.129B 0.00
Enzo Biochem (ENZ) United States $0.123B 0.00
Chiasma (CHMA) United States $0.123B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.122B 0.00
Equillium (EQ) United States $0.120B 0.00
XOMA (XOMA) United States $0.118B 0.00
Pluristem Therapeutics (PSTI) Israel $0.117B 0.00
Selecta Biosciences (SELB) United States $0.115B 0.00
Mustang Bio (MBIO) United States $0.113B 0.00
Fortress Biotech (FBIO) United States $0.112B 0.00
VolitionRX (VNRX) Singapore $0.110B 0.00
Catalyst Biosciences (CBIO) United States $0.110B 0.00
Signal Genetics (MGEN) United States $0.108B 0.00
NantKwest (NK) United States $0.106B 0.00
Checkpoint Therapeutics (CKPT) United States $0.105B 0.00
Neothetics (EVFM) United States $0.101B 0.00
Oncobiologics (OTLK) United States $0.099B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.096B 0.00
Aptose Biosciences (APTO) Canada $0.095B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.095B 0.00
Cel-Sci (CVM) United States $0.093B 0.00
Provention Bio (PRVB) United States $0.089B 0.00
ARAVIVE, INC (ARAV) United States $0.088B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.086B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.086B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.086B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.086B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.084B 0.00
Cocrystal Pharma (COCP) United States $0.083B 93.00
Idera Pharmaceuticals (IDRA) United States $0.083B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.082B 0.00
Applied Genetic Technologies (AGTC) United States $0.081B 0.00
Orgenesis (ORGS) United States $0.080B 0.00
VTv Therapeutics (VTVT) United States $0.079B 0.00
NewLink Genetics (NLNK) United States $0.077B 0.00
INMUNE BIO INC (INMB) United States $0.077B 0.00
OVID THERAPEUTC (OVID) United States $0.075B 0.00
Alimera Sciences (ALIM) United States $0.075B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.075B 0.00
Cidara Therapeutics (CDTX) United States $0.073B 0.00
SESEN BIO, INC (SESN) United States $0.070B 0.00
AEterna Zentaris (AEZS) United States $0.070B 13.34
Protalix BioTherapeutics (PLX) Israel $0.069B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.065B 0.00
Eyenovia (EYEN) United States $0.065B 0.00
Zosano Pharma (ZSAN) United States $0.064B 0.00
Celldex Therapeutics (CLDX) United States $0.064B 0.00
Ophthotech (OPHT) United States $0.062B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.062B 0.00
Proteon Therapeutics (PRTO) United States $0.062B 0.00
Prima BioMed (IMMP) Australia $0.061B 0.00
Alcobra (ARCT) United States $0.059B 0.00
Vascular Biogenics (VBLT) Israel $0.058B 0.00
ScPharmaceuticals (SCPH) United States $0.058B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
Arsanis (XFOR) United States $0.056B 0.00
Clearside Biomedical (CLSD) United States $0.056B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.055B 0.00
VistaGen Therapeutics (VTGN) United States $0.054B 0.00
ANCHIANO THERAP (ANCN) Israel $0.051B 0.00
Bellerophon Therapeutics (BLPH) United States $0.050B 0.00
Evogene (EVGN) Israel $0.050B 0.00
Entera Bio (ENTX) Israel $0.048B 0.00
VIVUS (VVUS) United States $0.048B 0.00
Curis (CRIS) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.045B 0.00
Leap Therapeutics (LPTX) United States $0.044B 0.00
TRACON Pharmaceuticals (TCON) United States $0.044B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.044B 0.00
DiaMedica Therapeutics (DMAC) United States $0.040B 0.00
Celsion (CLSN) United States $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
Aptevo Therapeutics (APVO) United States $0.036B 0.00
Caladrius Biosciences (CLBS) United States $0.036B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.035B 0.00
AquaBounty Technologies (AQB) United States $0.035B 0.00
Advaxis (ADXS) United States $0.034B 0.00
OncoSec Medical (ONCS) United States $0.034B 0.00
Oncolytics Biotech (ONCY) Canada $0.034B 0.00
Sophiris Bio (SPHS) United States $0.034B 0.00
Motif Bio Plc (MTFB) United States $0.033B 0.00
GTx (GTXI) United States $0.030B 0.00
Adial Pharmaceuticals (ADIL) United States $0.030B 0.00
Galena Biopharma (SLS) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
Vical (VICL) United States $0.026B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.026B 0.00
IMMURON LTD (IMRN) Australia $0.025B 0.00
CytRx (CYTR) United States $0.025B 0.00
Fibrocell Science Inc (FCSC) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
Novelion Therapeutics (NVLN) Canada $0.024B 0.00
BioPharmX (BPMX) United States $0.023B 0.00
Benitec Biopharma (BNTC) Australia $0.022B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Oragenics (OGEN) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.018B 0.00
IBio (IBIO) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Soligenix (SNGX) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.53
Genetic Technologies (GENE) Australia $0.015B 0.00
Apricus Biosciences (SEEL) United States $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Neuralstem (CUR) United States $0.012B 0.00
Synthetic Biologics (SYN) United States $0.011B 0.00
Pulmatrix (PULM) United States $0.011B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Histogenics (HSGX) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.003B 0.00
HOTH THERAPEUTC (HOTH) United States $0.000B 0.00